Alex Advani, PhD
Alex Advani has spent his consulting career applying his deep analytical experience and skills to biopharmaceutical strategy. His work includes launch strategy, site of care analysis, account profiling, opportunity assessments, and portfolio development strategy. He has deep expertise in multiple therapeutic areas such as hematology/oncology, genetic and rare disease, and infectious disease. Alex received Ph.D. and Master’s degrees in Genetics, Genomics, and Systems Biology from the University of Chicago and a B.A. in Biology from Duke University.